Wells Fargo’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200
Closed -$50 7721
2023
Q2
$50 Hold
200
﹤0.01% 7057
2023
Q1
$60 Hold
200
﹤0.01% 7063
2022
Q4
$80 Hold
200
﹤0.01% 6855
2022
Q3
$0 Hold
200
﹤0.01% 7661
2022
Q2
$0 Hold
200
﹤0.01% 7767
2022
Q1
$0 Hold
200
﹤0.01% 8101
2021
Q4
$1K Hold
200
﹤0.01% 7112
2021
Q3
$1K Buy
+200
New +$616 ﹤0.01% 6848

Other funds holding SLGCW

Wells Fargo's SLGCW Position: Q3 2023 in Review

Wells Fargo sold out of SomaLogic, Inc. Warrant (SLGCW) in Q3 2023, closing a stake of 200 shares — an estimated $50 sold.

Wells Fargo first reported a position in SLGCW in Q3 2021 and held it in 8 quarters. The position peaked at $1K in Q4 2021. 22 funds tracked by Wall St. Rank hold SLGCW as of Q3 2023.

  • Wells Fargo reported no remaining SomaLogic, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
  • Wells Fargo sold 200 SomaLogic, Inc. Warrant shares in Q3 2023, an estimated $50.
  • Wells Fargo first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 8 quarters.
  • Wells Fargo's SomaLogic, Inc. Warrant position peaked at $1K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q3 2023.

Based on Wells Fargo's 13F filing for Q3 2023, filed 13 Nov 2023.